ProZyme Inc. - A part of Agilent Revenue and Competitors
Estimated Revenue & Valuation
- ProZyme Inc. - A part of Agilent's estimated annual revenue is currently $3.7M per year.
- ProZyme Inc. - A part of Agilent's estimated revenue per employee is $155,000
Employee Data
- ProZyme Inc. - A part of Agilent has 24 Employees.
- ProZyme Inc. - A part of Agilent grew their employee count by -29% last year.
ProZyme Inc. - A part of Agilent's People
Name | Title | Email/Phone |
---|
ProZyme Inc. - A part of Agilent Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is ProZyme Inc. - A part of Agilent?
ProZyme is now part of Agilent Technologies, Inc. ProZyme is dedicated to advancing glycobiology research and improving biopharmaceutical analysis for optimal design and quality manufacturing of life saving therapies. The company supplies value-added kits, enzymes, standards and a complete CE system for biotherapeutic protein characterization and glycobiology research. ProZyme’s focus on R&D and innovation supports an agile product development program and a strong IP portfolio.
keywords:N/AN/A
Total Funding
24
Number of Employees
$3.7M
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4M | 24 | -11% | N/A |
#2 | $3.5M | 24 | -4% | N/A |
#3 | $7M | 25 | 4% | N/A |
#4 | $2.6M | 25 | -4% | N/A |
#5 | $1.8M | 25 | 4% | N/A |